The epidemiology of acute pancreatitis in Tasmania over a 12-year period: Is this a disease of disadvantage?

IF 2.8 2区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY
Richard C. Turner , Sauro Salomoni , Rachel E. Neale , Amanda Neil , Savio G. Barreto , Chee Y. Ooi , Daniel Croagh , Jeremy S. Wilson , Tony Pang , Minoti Apte
{"title":"The epidemiology of acute pancreatitis in Tasmania over a 12-year period: Is this a disease of disadvantage?","authors":"Richard C. Turner ,&nbsp;Sauro Salomoni ,&nbsp;Rachel E. Neale ,&nbsp;Amanda Neil ,&nbsp;Savio G. Barreto ,&nbsp;Chee Y. Ooi ,&nbsp;Daniel Croagh ,&nbsp;Jeremy S. Wilson ,&nbsp;Tony Pang ,&nbsp;Minoti Apte","doi":"10.1016/j.pan.2024.04.010","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>The global incidence of acute pancreatitis (AP) is increasing, but little information exists about trends in Australia. This study aimed to describe incidence trends, along with clinical and socio-demographic associations, in the state of Tasmania over a recent 12-year period.</p></div><div><h3>Methods</h3><p>The study cohort was obtained by linking clinical and administrative datasets encompassing the whole Tasmanian population between 2007 and 2018, inclusive. Pancreatitis case definition was based on relevant ICD-10 hospitalization codes, or elevated serum lipase or amylase in pathology data.</p><p>Age-standardised incidence rates were estimated, overall and stratified by sex, aetiology, and Index of Relative Socio-economic Disadvantage (IRSD).</p></div><div><h3>Results</h3><p>In the study period, 4905 public hospital AP episodes were identified in 3503 people. The age-standardised person-based incidence rate across the entire period was 54 per 100,000 per year. Incidence was inversely related to IRSD score; 71 per 100,000 per year in the most disadvantaged quartile compared to 32 in the least disadvantaged. Biliary AP incidence was higher than that of alcohol-related AP, although the greatest incidence was in “unspecified” cases. There was an increase in incidence for the whole cohort (average annual percent change 3.23 %), largely driven by the two most disadvantaged IRSD quartiles; the least disadvantaged quartile saw a slight overall decrease.</p></div><div><h3>Conclusion</h3><p>This is the first Australian study providing robust evidence that AP incidence is increasing and is at the upper limit of population-based studies worldwide. This increased incidence is greatest in socio-economically disadvantaged areas, meriting further research to develop targeted, holistic management strategies.</p></div>","PeriodicalId":19976,"journal":{"name":"Pancreatology","volume":null,"pages":null},"PeriodicalIF":2.8000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1424390324001091/pdfft?md5=bb50cbc6c08daf1d69cf11129451d999&pid=1-s2.0-S1424390324001091-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pancreatology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1424390324001091","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

The global incidence of acute pancreatitis (AP) is increasing, but little information exists about trends in Australia. This study aimed to describe incidence trends, along with clinical and socio-demographic associations, in the state of Tasmania over a recent 12-year period.

Methods

The study cohort was obtained by linking clinical and administrative datasets encompassing the whole Tasmanian population between 2007 and 2018, inclusive. Pancreatitis case definition was based on relevant ICD-10 hospitalization codes, or elevated serum lipase or amylase in pathology data.

Age-standardised incidence rates were estimated, overall and stratified by sex, aetiology, and Index of Relative Socio-economic Disadvantage (IRSD).

Results

In the study period, 4905 public hospital AP episodes were identified in 3503 people. The age-standardised person-based incidence rate across the entire period was 54 per 100,000 per year. Incidence was inversely related to IRSD score; 71 per 100,000 per year in the most disadvantaged quartile compared to 32 in the least disadvantaged. Biliary AP incidence was higher than that of alcohol-related AP, although the greatest incidence was in “unspecified” cases. There was an increase in incidence for the whole cohort (average annual percent change 3.23 %), largely driven by the two most disadvantaged IRSD quartiles; the least disadvantaged quartile saw a slight overall decrease.

Conclusion

This is the first Australian study providing robust evidence that AP incidence is increasing and is at the upper limit of population-based studies worldwide. This increased incidence is greatest in socio-economically disadvantaged areas, meriting further research to develop targeted, holistic management strategies.

塔斯马尼亚 12 年间急性胰腺炎的流行病学:这是一种弱势疾病吗?
背景:全球急性胰腺炎(AP)的发病率正在上升,但有关澳大利亚发病趋势的信息却很少。本研究旨在描述塔斯马尼亚州最近12年的发病趋势以及临床和社会人口学关联:研究队列是通过连接 2007 年至 2018 年(含)期间塔斯马尼亚州全体人口的临床和行政数据集获得的。胰腺炎病例的定义基于相关的ICD-10住院代码,或病理数据中血清脂肪酶或淀粉酶的升高。我们估算了总体年龄标准化发病率,并按性别、病因和相对社会经济劣势指数(IRSD)进行了分层:在研究期间,共发现 3503 人中有 4905 例公立医院急性呼吸道感染病例。在整个研究期间,以年龄为标准的个人发病率为每年每 10 万人中有 54 人发病。发病率与 IRSD 评分成反比;在最弱势的四分位中,每年每十万人中有 71 人发病,而在最弱势的四分位中,每年每十万人中有 32 人发病。胆道 AP 的发病率高于酒精相关 AP,但 "未指定 "病例的发病率最高。整个队列的发病率有所上升(年均百分比变化率为 3.23%),这主要是由两个处境最不利的 IRSD 四分位组推动的;处境最不利的四分位组的发病率总体上略有下降:这是澳大利亚的第一项研究,它提供了有力的证据,证明 AP 发病率正在上升,并已达到全球人口研究的上限。在社会经济条件较差的地区,这种发病率的增加幅度最大,值得进一步研究,以制定有针对性的综合管理策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Pancreatology
Pancreatology 医学-胃肠肝病学
CiteScore
7.20
自引率
5.60%
发文量
194
审稿时长
44 days
期刊介绍: Pancreatology is the official journal of the International Association of Pancreatology (IAP), the European Pancreatic Club (EPC) and several national societies and study groups around the world. Dedicated to the understanding and treatment of exocrine as well as endocrine pancreatic disease, this multidisciplinary periodical publishes original basic, translational and clinical pancreatic research from a range of fields including gastroenterology, oncology, surgery, pharmacology, cellular and molecular biology as well as endocrinology, immunology and epidemiology. Readers can expect to gain new insights into pancreatic physiology and into the pathogenesis, diagnosis, therapeutic approaches and prognosis of pancreatic diseases. The journal features original articles, case reports, consensus guidelines and topical, cutting edge reviews, thus representing a source of valuable, novel information for clinical and basic researchers alike.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信